Advertisement
Trending - Altmetric
-
Osimertinib and palbociclib in an EGFR-mutated NSCLC with primary CDK4 amplification after progression under osimertinib
-
Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis
-
Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer
-
Metabolic pathway-based subtypes associate glycan biosynthesis and treatment response in head and neck cancer